Synergistic effect of silver nanoparticles and polymyxin B against biofilm produced by Pseudomonas aeruginosa isolates of pus samples in vitro
Source abstract
Abstract
Pseudomonas aeruginosa (P. aeruginosa) is an aerobic gram-negative, non-spore forming, rod-shaped bacterium. It accelerates the decline in lung function and ultimately leads to increased mortality and morbidity rate. Survival and virulence of P. aeruginosa is due to its biofilm formation ability. The main aim of this study was to test the synergistic effect of silver nanoparticles (AgNPs) in combination with Polymyxin B against biofilms of P. aeruginosa. A total of 500 pus aspirations were collected and bacterial pathogens were identified. Biofilm formation was attained using a glass tube method and microtiter plate assay. The minimum inhibitory concentration of Polymyxin B was determined using agar well diffusion method. Silver nanoparticles were synthesized by chemical reduction method followed by determination of their anti-pseudomonal ability separately and in combination with Polymyxin B using microtiter plate assay. Our results showed that 120 out of 500 samples were Pseudomonas positive. The ratio of multidrug-resistant (MDR) in our collected Pseudomonas samples was 83% (25/30). Generally, the minimum inhibitory concentration (MIC) of Polymyxin B was 16 µg/mL and that of AgNPs was null. However, AgNPs showed great synergistic effect in combination with Polymyxin B. Synergistically, the efficacy of Polymyxin B was enhanced four times as compared to unaided Polymyxin B.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Antibiotic Resistance in Bacteria · Bacterial biofilms and quorum sensing · Nosocomial Infections in ICU
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Microbiology and Biotechnology, Abasyn University Peshawar
Department of Microbiology, University of Swabi
Institute of Biotechnology and Genetic Engineering (IBGE), The University of Agriculture Peshawar
Department of Botany, Abdul Wali Khan University Mardan
Drug Regulatory Authority of Pakistan
Department of Biotechnology, Bacha Khan University Charsada
References (38)
Show source-provided references
1. 10.1016/0002-9394(81)90649-810.1016/0002-9394(81)90649-8 ↗
2. 10.1164/rccm.200408-1044SO10.1164/rccm.200408-1044SO ↗
3. 10.1002/ppul.2061910.1002/ppul.20619 ↗
4. 10.1186/2047-2994-3-3210.1186/2047-2994-3-32 ↗
5. 10.12669/pjms.294.365210.12669/pjms.294.3652 ↗
6. 10.1097/00003246-199905000-0002010.1097/00003246-199905000-00020 ↗
7. 10.1128/AAC.37.9.174910.1128/AAC.37.9.1749 ↗
8. Japoni A, Farshad S, Alborzi A. Pseudomonas aeruginosa: burn infection, treatment and antibacterial resistance. Iran Red Crescent Med J. 2009;3:244–253.
9. 10.1128/CMR.15.2.167-193.200210.1128/CMR.15.2.167-193.2002 ↗
10. 10.9790/3008-085364010.9790/3008-0853640 ↗
11. 10.1038/npjbiofilms.2015.510.1038/npjbiofilms.2015.5 ↗
12. 10.1007/978-3-540-68119-910.1007/978-3-540-68119-9 ↗
13. 10.2166/wst.2010.02210.2166/wst.2010.022 ↗
14. 10.1016/j.watres.2007.08.02610.1016/j.watres.2007.08.026 ↗
15. 10.1007/978-3-642-21289-5_210.1007/978-3-642-21289-5_2 ↗
16. 10.20452/pamw.178010.20452/pamw.1780 ↗
17. 10.1093/jac/dku18410.1093/jac/dku184 ↗
18. Deacon J, Abdelghany SM, Quinn DJ, et al. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa. Microbiol Rev. 2002;15:194–222.
19. 10.1002/bip.2209510.1002/bip.22095 ↗
20. 10.4155/fmc-2016-009110.4155/fmc-2016-0091 ↗
21. 10.1016/S1473-3099(15)00424-710.1016/S1473-3099(15)00424-7 ↗
22. 10.1016/j.chembiol.2015.01.00210.1016/j.chembiol.2015.01.002 ↗
23. 10.1128/AAC.03163-1410.1128/AAC.03163-14 ↗
24. Ravishankar Rai V, Jamuna Bai A. Nanoparticles and their potential application as antimicrobials. Science against microbial pathogens,” communicating current research and technological advances. In: Méndez-Vilas A, editor. Science against microbial pathogens: communicating current research and technological advances. 2011, p. 197–209. FORMATEX 2011.
25. 10.5185/amlett.2011.120610.5185/amlett.2011.1206 ↗
26. 10.1021/am402618w10.1021/am402618w ↗
27. 10.1016/j.biomaterials.2009.07.03010.1016/j.biomaterials.2009.07.030 ↗
28. Abbaszadegan A, Ghahramani Y, Gholami A, et al. The effect of charge at the surface of silver nanoparticles on antimicrobial activity against gram-positive and gram-negative bacteria: a preliminary study. Journal of Nanomaterials. 2015;16:53.
29. 10.1016/j.colsurfb.2010.10.00810.1016/j.colsurfb.2010.10.008 ↗
30. 10.1021/acsami.6b0016110.1021/acsami.6b00161 ↗
31. 10.18203/2320-6012.ijrms2017299010.18203/2320-6012.ijrms20172990 ↗
32. Andhale J, Misra R, Gandham N, et al. Incidence of Pseudomonas aeruginosa with special reference to drug resistance and biofilm formation from clinical samples in tertiary care hospital. J Pharm Biomed Sci. 2016;6:387–391.
33. Sharma S, Srivastava P. Resistance of antimicrobial in Pseudomonas aeruginosa. Intjcurrmicrobiolappsci. 2016;5:121–128.
34. 10.1186/1471-2415-13-5710.1186/1471-2415-13-57 ↗
35. 10.2147/IJN.S10416610.2147/IJN.S104166 ↗
36. 10.1016/j.nano.2011.11.00710.1016/j.nano.2011.11.007 ↗
37. Markowska K, Grudniak AM, Wolska KI. Silver nanoparticles as an alternative strategy against bacterial biofilms. Acta Biochim Pol. 2013;60:523–530.
38. 10.1016/j.nano.2009.04.00610.1016/j.nano.2009.04.006 ↗